AFFIVANT

Welcome to the Brand page for “AFFIVANT”, which is offered here for Pharmaceutical preparations for human use, for the prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations for human use comprising cell-based therapies for the treatment of oncological, neurological and immunological diseases and disorders; biologic preparations for medical and therapeutic purposes, for the prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical and biological preparations for prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncological, neurological and immunological diseases and disorders;providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions;scientific and technological services, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine and research and design relating thereto; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine;.

Its status is currently believed to be active. Its class is unavailable. “AFFIVANT” is believed to be currently owned by “Affivant Sciences GmbH”.